Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC419

Tírzepatíð

  • Status:
    Veitt
  • Application date:
    26.1.2023
  • Application published:
    15.2.2023
  • Grant published:
    15.9.2024
  • Max expiry date:
    18.9.2037
  • Medicine name:
    Mounjaro
  • Medicine for children:
    No

Timeline

Today
26.1.2023Application
15.2.2023Publication
15.9.2024Registration
18.9.2037Expires

Marketing license

  • IS authorization number:
    EU/1/22/1685/001-003; EU/1/22/1685/004-006; EU/1/22/1685/007-009; EU/1/22/1685/010-012; EU/1/22/1685/013-015; EU/1/22/1685/016-018
  • Date:
    11.10.2022
  • Foreign authorization number:
    EU/1/22/1685
  • Date:
    15.9.2022

Owner

  • Name:
    Eli Lilly and Company
  • Address:
    Lilly Corporate Center, Indianapolis US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 16.09.2024

Upload documents